Medicare Part D Patients Bear The Cost Of Me Too Brand-Name Drugs
Author: Nicole M. Gastala, Peter Wingrove, Anne Gaglioti, Stephen Petterson, Andrew Bazemore
Prescription drugs are a major source of US health care expenditure. “Me too” brand-name medications contribute to the cost of drugs, which is substantial for consumers. In 2013 patient copayments averaged 10.5 times more for two commonly prescribed brand-name medications versus generic therapeutic alternatives.
